Person

Back to overview Show all

Projects as responsible applicant

Responsible applicant Institution of higher education Start End date Funding scheme

Anti-inflammatory treatment to reduce atherosclerosis and acute myocardial ischemia
Mach Francois University of Geneva - GE 01.01.2005 31.12.2007 Project funding

Role of TGF-ß1-deficient B cells and follicular regulatory T cells in atherosclerosis
Mach Francois University of Geneva - GE 01.04.2018 31.03.2022 Project funding

Selective anti-inflammatory treatments to reduce post-infarction heart failure
Mach Francois University of Geneva - GE 01.01.2011 31.12.2013 Project funding

Anti-inflammatory approaches to reduce ischemia-reperfusion injury during acute myocardial infarction
Mach Francois University of Geneva - GE 01.01.2008 31.12.2010 Project funding

Role of B cell subsets in atherosclerotic plaque vulnerability and peripheral tissue ischemic injury
Mach Francois University of Geneva - GE 01.05.2014 30.04.2017 Project funding

Role of Vascular Wall Chemokines in the Pathogenesis of Atherosclerosis.(zu SCORE A)
Mach Francois University of Geneva - GE 01.01.1999 31.12.2001 Project funding

Role of Vascular Wall Chemokines in the Pathogenesis of Atherosclerosis. (SCORE A)
Mach Francois University of Geneva - GE 01.01.1999 31.12.2005 Ambizione

Projects as co-applicant

Responsible applicant Institution of higher education Start End date Funding scheme

ADRIE - antiplatelet drug resistances ans ischemic events
Fontana Pierre University of Geneva - GE 01.04.2007 30.09.2008 Project funding

Inflammation and acute coronary syndrome (ACS) - novel strategies for prevention and clinical management
Lüscher Thomas F. University of Zurich - ZH 01.02.2012 31.01.2015 SPUM

Role of visfatin on inflammatory atherosclerotic vulnerability for ischemic stroke
Montecucco Fabrizio University of Geneva - GE 01.04.2011 31.03.2014 Project funding

Inflammation and acute coronary syndrome (ACS) - novel strategies for prevention and clinical management
Lüscher Thomas F. University of Zurich - ZH 01.02.2009 31.01.2012 SPUM

Relationship between increasing body weight, endocannabinoids, leptin and coronary circulatory disfunction
Schindler Thomas Hellmut University of Geneva - GE 01.02.2009 31.01.2012 Project funding

ER Niacin/laropiprant impact on cardiovascular markers and atheroprogression in HIV-infected individuals on cART: the NILACH trial
Calmy Alexandra University of Geneva - GE 01.01.2012 31.12.2015 Project funding (special)

Projects as project partner

Responsible applicant Institution of higher education Start End date Funding scheme

-